J Pediatr Endocrinol Metab. 2018 Nov 16. pii: /j/jpem.ahead-of-print/jpem-2018-0184/jpem-2018-0184.xml. doi: 10.1515/jpem-2018-0184. [Epub ahead of print]
Targeted next generation sequencing in patients with maturity-onset diabetes of the young (MODY).
Özdemir TR1, Kırbıyık Ö1, Dündar BN2, Abacı A3, Kaya ÖÖ1, Çatlı G2, Özyılmaz B1, Acar S3, Koç A1, Güvenç MS1, Kutbay YB1, Erdoğan KM1.
Abstract
Background Maturity-onset diabetes of the young (MODY) is a common form of monogenic diabetes. Fourteen genes have been identified, each leading to cause a different type of MODY. The aims of this study were to reveal both known and novel variants in MODY genes in patients with MODY using targeted next generation sequencing (NGS) and to present the genotype-phenotype correlations. Methods Mutation analysis of MODY genes (GCK, HNF1A, HNF4A, HNF1B, ABCC8, INS and KCNJ11) was performed using targeted NGS in 106 patients with a clinical diagnosis of MODY. The variants were evaluated according to American College of Medical Genetics and Genomics (ACMG) Standards and Guidelines recommendations. Results A total of 18 (17%) variants were revealed among all patients. Seven variants in GCK, six in HNF4A, four in HNF1A and one in ABCC8 genes were found. Eight of them were previously published and 10 of them were assessed as novel pathogenic or likely pathogenic variants. Conclusions While the most frequent mutations are found in the HNF1A gene in the literature, most of the variants were found in the GCK gene in our patient group using the NGS method, which allows simultaneous analysis of multiple genes in a single panel.
KEYWORDS:
MODY; genotype; next generation sequencing; novel mutation; phenotype
- PMID:
- 30447144
- DOI:
- 10.1515/jpem-2018-0184
No hay comentarios:
Publicar un comentario